Home › Cancer (all types) › NCT00872495
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
RecruitingObservational studyHealthy volunteers welcome
Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer of the Bladder and Kidney
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up) * Control Group: No known evidence of bladder cancer-one urine sample * \> than 18 years of age Exclusion Criteria: * \< than 18 years of age
About the study
The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence
Sponsor: Lahey Clinic · Participants: 500 · Started: 2002-09
Contact the study team
- Kimberly Rieger-Christ, PhD · Phone: 781-744-2969
- Linda M. Topjian · Phone: 781-744-8711
Official record on ClinicalTrials.gov — NCT00872495
Locations in the U.S.
| Massachusetts | Lahey Clinic, Inc., Burlington |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.